Skip to main content

GSA CAPITAL PARTNERS LLP

Position in IRWD — Ironwood Pharmaceuticals Inc

CIK 1362033 LONDON, X0

Position in IRWD

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$2,297,101
+$370,766 QoQ
Shares Held
654,445
+14.5% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
16 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in IRWD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $10,107,066 across 16 Drug Manufacturers - Specialty & Generic names. IRWD ranks #1 (22.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IRWD
Ironwood Pharmaceuticals Inc
This page
654,445 $2,297,101

All Filings in IRWD

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,297,101 654,445
2025-12-31 $1,926,335 571,613
2025-09-30 $405,482 309,529
2025-06-30 $519,019 720,860
2025-03-31 $771,273 524,676
2024-12-31 $61,430 13,867
2024-09-30 $1,446,915 351,193
2024-06-30 $776,571 119,106
2024-03-31 $1,534,458 176,172
2023-06-30 $676,767 63,606
2023-03-31 $1,086,274 103,258
2022-12-31 $755,158 60,949
2022-09-30 $496,679 47,942
2022-06-30 $121,076 10,501
2022-03-31 $1,031,320 81,981
2020-09-30 $855,533 95,165